Home
Conditions
Carcinoma

Clinical trial condition

Carcinoma

Explore clinical trials studying Carcinoma. Study availability and eligibility vary by location and protocol.

8,891 public trials 2,118 recruiting studies

Refine in advanced search Browse all conditions

Carcinoma trial results

Active, not recruiting

HAIC Sequential TAE Combined With Tislelizumab and Surufatinib in Unresectable Intrahepatic Cholangiocarcinoma

NCT06239532

Conditions: Adenocarcinoma, Carcinoma, Cholangiocarcinoma, +4 more
Locations: Qilu Hospital of Shandong University Jinan, Shandong, China

View Trial Details

Active, not recruiting

Construction of a Recurrence Risk Prediction Model for Liver Resection Based on Drug Sensitivity of Patient-derived Hepatocellular Carcinoma Organoid

NCT06699524

Conditions: Adenocarcinoma, Carcinoma, Carcinoma, Hepatocellular, +9 more
Locations: Eastern Hepatobiliary Surgery Hospital, Naval Medical University, Shanghai, Shanghai Municipality, China

View Trial Details

Active, not recruiting

Prognostic Counselling in Palliative Head and Neck Cancer (ProCoPall)

NCT06699316

Conditions: Carcinoma, Carcinoma, Squamous Cell, Head and Neck Neoplasms, +5 more
Locations: Erasmus MC Rotterdam, Netherlands

View Trial Details

Active, not recruiting

HOT: HIPEC in Ovarian Cancer as Initial Treatment

NCT02124421

Conditions: Adnexal Diseases, Carcinoma, Carcinoma, Ovarian Epithelial, +25 more
Locations: Mercy Medical Center Baltimore, Maryland, United States

View Trial Details

Active, not recruiting

A Study of XL092 as Single-Agent and Combination Therapy in Subjects With Solid Tumors

NCT03845166

Conditions: Adenocarcinoma, Carcinoma, Carcinoma, Renal Cell, +27 more
Locations: Exelixis Clinical Site #6 Duarte, California, United States

Exelixis Clinical Site #49 La Jolla, California, United States

Exelixis Clinical Site #7 Los Angeles, California, United States

Exelixis Clinical Site #84 Los Angeles, California, United States

View all 86 locations

View Trial Details

Active, not recruiting

Antibiotic Treatment and Long-term Outcomes of Patients With Pseudomyxoma Peritonei of Appendiceal Origin

NCT02387203

Conditions: Adenocarcinoma, Adenocarcinoma, Mucinous, Appendiceal Neoplasms, +15 more
Locations: Mercy Medical Center Baltimore, Maryland, United States

View Trial Details

Active, not recruiting

Combination of Tislelizumab and Chemoradiotherapy in Esophageal Cancer (EC-CRT-002)

NCT05520619

Conditions: Carcinoma, Carcinoma, Squamous Cell, Digestive System Diseases, +13 more
Locations: Mian Xi Guangzhou, Guangdong, China

View Trial Details

Active, not recruiting

A Phase 1/2a Study of 23ME-00610 in Patients With Advanced Solid Malignancies

NCT05199272

Conditions: Adenocarcinoma, Adnexal Diseases, Bronchial Neoplasms, +45 more
Locations: Stanford Cancer Institute Palo Alto, California, United States

Emory University Atlanta, Georgia, United States

Karmanos Cancer Institute Detroit, Michigan, United States

R.J.Zuckerberg Cancer Center Lake Success, New York, United States

View all 13 locations

View Trial Details

Active, not recruiting

Radiofrequency Ablation Using Combined RF Energy Delivery Mode and Octopus Electrodes for Hepatocellular Carcinoma

NCT06682377

Conditions: Adenocarcinoma, Carcinoma, Carcinoma, Hepatocellular, +9 more
Locations: Seoul National University Hospital Seoul, South Korea

View Trial Details

Active, not recruiting

Phase II Trial of Pembrolizumab in Recurrent or Metastatic HNSCC

NCT03813836

Conditions: Carcinoma, Carcinoma, Squamous Cell, Head and Neck Neoplasms, +7 more
Locations: Aberdeen Royal Infirmary (NHS Grampian) Aberdeen, United Kingdom

Bristol Haematology and Oncology Centre (University Hospital Bristol NHS Foundation Trust) Bristol, United Kingdom

Western General Hospital (NHS Lothian) Edinburgh, United Kingdom

East Suffolk and North Essex NHS Foundation Trust Ipswich, United Kingdom

View Trial Details

Carcinoma

Carcinoma trial results

Related conditions